查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1820122

肠溶软胶囊市场报告（按类型、应用、配销通路和地区）2025-2033

Enteric Softgel Capsules Market Report by Type, Application, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球肠溶软胶囊市场规模达27亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到37亿美元，2025-2033年期间的复合年增长率（CAGR）为3.6%。市场成长主要受全球老年人口成长、慢性疾病和营养缺乏症盛行率上升以及营养和膳食补充剂日益普及的驱动。

肠溶软胶囊市场趋势：

慢性病盛行率不断上升

糖尿病、心血管疾病和胃肠道疾病等慢性疾病的盛行率不断上升，大大推动了肠溶软胶囊市场的成长。根据美国疾病管制与预防中心的数据，美国约有1.29亿人患有至少一种主要慢性疾病，包括心臟病、癌症、糖尿病、肥胖和高血压。此外，美国十大主要死因中有五种是或与可预防和可治疗的慢性疾病密切相关。此外，在过去二十年中，慢性疾病的盛行率稳步上升，预计这一趋势还将持续。肠溶软胶囊能够持续标靶释放药物，这对于治疗通常需要长期治疗的疾病非常有益。透过在肠道而不是胃部释放药物，这些胶囊可以确保药物在最佳作用区域被吸收。这种标靶给药是治疗慢性疾病的理想选择，因为它可以增强疗效并减少副作用。随着人口老化、久坐不动的生活方式以及饮食习惯的改变导致全球慢性病负担加重，肠溶软胶囊和其他复杂的药物输送技术的需求可能会越来越大。

对营养补充品的偏好日益增加

推动肠溶软胶囊市场收入成长的另一个因素是消费者对膳食补充剂日益增长的兴趣。根据美国国家医学图书馆的数据，全球营养保健品和补充剂市场在过去十年中稳步增长，据报导2019年的价值为3530亿美元。该领域的研究也在成长，PubMed上已发表的与营养保健品或膳食补充剂相关的文章超过70,000篇。此外，由严重急性呼吸道症候群冠状病毒2（SARS-CoV-2）引起的冠状病毒病（COVID-19）大流行始于2019年11月，导致膳食补充剂和营养保健品的销量在2020年初进一步增长。营养保健品产业广泛使用肠溶软胶囊来提供维生素、矿物质和其他营养补充品。这些胶囊具有许多好处，包括增加营养吸收和生物利用度，保护脆弱成分免受胃酸侵蚀，并提高客户便利性和依从性。随着人们越来越意识到营养补充品的健康益处，越来越多的人将营养补充品纳入日常生活。这一趋势在老年人群体和注重健康的消费者中尤其明显，他们希望透过补充剂来预防或治疗疾病。

老年人口不断增加

不断增长的老年人口是肠溶软胶囊市场价值成长的另一个主要因素。根据联合国 (UN) 统计，全球 65 岁及以上人口预计将成长一倍以上，从 2021 年的 7.61 亿增加到 2050 年的 16 亿。 80 岁及以上人口的成长速度甚至更快。老年人通常有特殊的医疗保健需求，例如管理多种慢性疾病，需要易于吞嚥、对胃肠道友善的药物。肠溶软胶囊可以满足这些需求，它提供了一种实用且高效的处方药和膳食补充剂的递送方法。由于老年族群中消化问题较常见，这些胶囊的肠溶衣尤其有用。此外，随着预期寿命的延长和出生率的下降，世界老年人口正在不断扩大。肠溶软胶囊可提高服药依从性和治疗效果，预计随着人口结构转变，这类医疗保健产品的需求将会增加。

肠溶软胶囊市场区隔：

按类型分列：

  • 明胶胶囊
  • 非明胶软胶囊

明胶胶囊占大部分市场份额

根据肠溶胶囊市场预测，明胶胶囊因其卓越的生物相容性和吸收性而广受欢迎。明胶源自动物胶原蛋白，是一种易于人体吸收和消化的天然蛋白质。由于其生物相容性，它对各种消费者（包括胃敏感或饮食受限的消费者）来说都是安全的。明胶胶囊也因其高生物利用度（即活性物质能够被血液有效吸收）而闻名。因此，用于製造软胶囊的明胶需求不断增长。根据美国国家医学图书馆的数据，2020 年明胶市场规模达到 31.8 亿美元，并且预计到 2024 年将达到 40.8 亿美元，正如同一报告所预测的那样。

按应用分类：

  • 健康补充品
  • 製药

保健品占业界最大份额

保健品市场占据主导地位，这主要是因为人们越来越意识到维护整体健康和福祉的重要性。根据Research Gate的数据，53.7%的受访者根据医生的建议服用膳食补充剂，28.5%的受访者自行决定服用，15.9%的受访者听从朋友的建议服用；87.4%的受访者在药店购买补充剂。随着健康产业的发展，越来越多的人积极关注自身健康，并寻求有助于增强免疫力、提供重要营养素和预防慢性疾病的补充剂。肠溶软胶囊可以保护脆弱成分免受胃酸侵蚀，提高肠道吸收率和生物利用度，因此是这些营养素的理想输送方式。

按配销通路细分：

  • 超市和大卖场
  • 药局和药局
  • 网上商店

药房和药局是主要的细分市场

药房和药局在市场中占有相当大的份额。这些分布广泛且消费者友好的零售点为处方药和营养补充剂提供了实用的销售点。药剂师可以提供专业指导，顾客经常选择从药局购买健康相关产品，从而确保他们的决定是明智的。根据麦肯锡发布的报告，零售连锁店是四种药局类型中规模最大、最普遍的，占2021年门市总数的三分之一，约占处方收入的三分之一。以每家店计算，零售连锁店每年配发约138,000张处方，比杂货店多出约50%，杂货店是美国零售点数量第二多的处方药配药商。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美引领市场，占据最大的肠溶软胶囊市场份额

该报告还对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告指出，北美是肠溶软胶囊最大的区域市场。

北美肠溶软胶囊市场前景看好的一个重要驱动因素是慢性病盛行率的上升。根据美国国家医学图书馆的数据，美国50岁及以上人口数量将从2020年的1.3725亿增加61.11%，到2050年将达到2.2113亿。在50岁及以上人口中，患有至少一种慢性病的人数预计将从2020年的7,152.2万人增加99.5%，到2050年将达到1.4266亿。主要由于人口老化和生活方式的选择，糖尿病、心血管疾病和胃肠道疾病等疾病在该地区普遍存在。肠溶软胶囊可针对缓释药物，这对通常需要长期治疗的慢性病患者非常有益。这些胶囊是管理慢性病的建议选择，因为它们可以增强治疗效果并最大限度地减少副作用。北美巨大的市场份额主要归因于慢性病盛行率的上升，这反过来又推动了对高效实用的药物输送方法的需求。

（请注意，这只是关键参与者的部分名单，完整名单将在报告中提供。）

  • 根据肠溶软胶囊市场研究报告，主要参与者正在建立策略联盟和合作伙伴关係，以巩固其地位。他们也透过与学术机构、研究中心和其他製药公司合作进行创新。这些合作伙伴关係通常促成技术和资讯的交流以及新产品的共同开发，所有这些都极大地增强了企业的竞争优势。提高产能是肠溶软胶囊产业主要竞争对手使用的另一个重要策略。企业可以透过投资新的生产设施或改造现有的生产设施来提高产能和营运效率。此外，企业正在进入新兴市场，这些市场对先进医药产品的需求正在不断增长，这提供了巨大的成长机会。

本报告回答的关键问题

  • 2024年全球肠溶软胶囊市场规模是多少
  • 2025-2033年全球肠溶软胶囊市场的预期成长率是多少
  • COVID-19 对全球肠溶软胶囊市场有何影响
  • 推动全球肠溶软胶囊市场的关键因素有哪些
  • 全球肠溶软胶囊市场按类型划分如何？
  • 根据应用，全球肠溶软胶囊市场如何分布
  • 根据配销通路，全球肠溶软胶囊市场如何分布
  • 全球肠溶软胶囊市场的主要区域有哪些
  • 全球肠溶软胶囊市场的主要参与者/公司有哪些

本报告回答的关键问题

  • 2024年全球肠溶软胶囊市场规模？ 2025-2033年全球肠溶软胶囊市场的预期成长率为何？
  • COVID-19 对全球肠溶软胶囊市场有何影响？
  • 推动全球肠溶软胶囊市场发展的关键因素有哪些？
  • 全球肠溶软胶囊市场按类型分为哪些类型？
  • 根据应用，全球肠溶软胶囊市场是如何分布的？
  • 根据配销通路，全球肠溶软胶囊市场如何分布？
  • 全球肠溶软胶囊市场的主要区域有哪些？
  • 全球肠溶软胶囊市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球肠溶软胶囊市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 明胶胶囊
  • 非明胶软胶囊

第七章：市场区隔：依应用

  • 健康补充品
  • 製药

第八章：市场区隔：按配销通路

  • 超市和大卖场
  • 药局和药局
  • 网上商店

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Aenova Group GmbH
    • BASF SE
    • Catalent, Inc.
    • Colorcon Inc.
    • Fuji Capsule Co., Ltd.
    • Lonza Group AG
    • Now Health Group, Inc.
    • ProCaps Group
    • Super Spectrim
    • Thermo Fisher Scientific, Inc.
Product Code: SR112025A4232

The global enteric softgel capsules market size reached USD 2.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.7 Billion by 2033, exhibiting a growth rate (CAGR) of 3.6% during 2025-2033. The market is primarily driven by the growing global geriatric population, the rising prevalence of chronic medical disorders and nutrient-deficient diseases, and the growing acceptance of nutritional and dietary supplements.

Enteric Softgel Capsules Market Trends:

Growing prevalence of chronic diseases

The enteric softgel capsule market growth is significantly driven by the rising prevalence of chronic diseases like diabetes, cardiovascular disease, and gastrointestinal disorders. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease including heart disease, cancer, diabetes, obesity, and hypertension. Besides, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Moreover, over the past two decades prevalence has increased steadily, and this trend is expected to continue. Enteric softgel capsules offer a continuous and targeted release of medication, which is beneficial for treating illnesses that often require long-term treatment. By releasing its contents in the intestines instead of the stomach, these capsules make sure the medication is absorbed where it works best. This targeted administration is a desirable alternative for managing chronic diseases since it can enhance therapeutic outcomes and lessen side effects. With aging populations, sedentary lifestyles, and changing dietary habits contributing to the global burden of chronic diseases, enteric softgel capsules and other sophisticated drug delivery technologies are likely to become more and more in demand.

Increasing preference toward nutritional supplements

Another factor propelling the enteric softgel capsule market revenue is the growing inclination of consumers toward dietary supplements. As per the National Library of Medicine, the global nutraceuticals and supplements market has steadily grown over the past decade and was reported to be worth $353 Billion in 2019. Research in the field has also grown, with over 70,000 published articles available in PubMed relating to nutraceuticals or dietary supplements respectively. Besides, the occurrence of the coronavirus disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) starting in November 2019 led to an even greater increase in sales of dietary supplements and nutraceuticals in early 2020. The nutraceutical sector uses enteric softgel capsules extensively to provide vitamins, minerals, and other nutritional supplements. These capsules have a number of benefits, including as increased nutrient absorption and bioavailability, shielding delicate components from stomach acids, and improving customer convenience and compliance. More people are including nutritional supplements in their regular routines as awareness of their health advantages develops. This trend is especially prominent among older populations and health-conscious consumers who want to use supplements to prevent or treat medical issues.

Rising geriatric population

Another major aspect increasing the enteric softgel capsule market value is the growing geriatric population. According to the United Nations (UN), the global population aged 65 years or older is expected to be more than double, increasing from 761 million in 2021 to 1.6 billion by 2050. The population aged 80 years or older is growing at an even faster rate. Elderly people frequently have particular healthcare demands, such as managing several chronic illnesses and requiring easy-to-swallow, gastrointestinal-friendly drugs. These criteria are met by enteric softgel capsules, which provide a practical and efficient method of delivering prescription drugs and dietary supplements. These capsules' enteric coating is especially helpful as digestive problems are more common in the elderly population. Additionally, as life expectancy rises and birth rates fall, the world's senior population is expanding. Enteric softgel capsules, which can improve medication adherence and treatment outcomes, are among the healthcare items that are predicted to see an increase in demand as a result of this demographic transition.

Enteric Softgel Capsules Market Segmentation:

Breakup by Type:

  • Gelatin Capsules
  • Non-Gelatin Softgel Capsules

Gelatin capsules accounts for the majority of the market share

As per enteric capsules market forecast, gelatin capsules are widely preferred due to their exceptional biocompatibility and absorption. Derived from animal collagen, gelatin is an easily absorbed and digested natural protein by the human body. It is also safe for a variety of consumers including those with sensitive stomachs or dietary restrictions due to its biocompatibility. Gelatin capsules are also renowned for having a high bioavailability, or the ability of the active substances to be effectively absorbed into the bloodstream. Hence, there is an escalating demand for gelatin for manufacturing softgel capsules. As per National Liabrary of Medicine, the market for gelatin in 2020 reached USD 3.18 Billion and is further expected to reach USD 4.08 Billion by 2024 as forecasted in the same report.

Breakup by Application:

  • Health Supplements
  • Pharmaceuticals

Health supplements hold the largest share of the industry

The market is dominated by health supplements primarily due to the increasing awareness of the value of preserving general health and wellbeing. According to the Research Gate, 53.7 % of the participants of the survey took dietary supplements upon the doctor's advice, 28.5 % took them with their own decision, and 15.9 % took them after friend advice; 87.4 % of the participants bought supplements in the pharmacy. As the wellness sector grows, more people are taking an active role in their health and looking for supplements that help boost immunity, deliver vital nutrients, and stave against chronic illnesses. As enteric softgel capsules can shield delicate components from stomach acids, improving absorption and bioavailability in the intestines, they are an appealing delivery option for these nutrients.

Breakup by Distribution Channel:

  • Supermarkets and Hypermarkets
  • Pharmacy and Drug Stores
  • Online Stores

Pharmacy and drug stores represent the leading market segment

Pharmacy and drug stores hold a significant market share in the market. These widely dispersed and consumer-friendly retail locations offer a practical point of sale for prescription drugs and nutritional supplements. Pharmacists can offer expert guidance, customers frequently choose to purchase health-related products from pharmacies, guaranteeing that their decisions are well-informed. As per the report published by Mckinsey, retail chains are the largest and most prevalent of the four pharmacy types, representing a third of stores and about a third of prescription revenues in 2021. On a per-store basis, retail chains dispense approximately 138,000 prescriptions annually about 50 percent more than grocers, the next largest prescription dispensers per retail location in US.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest enteric softgel capsules market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for enteric softgel capsules.

An important driver creating a favorable enteric softgel capsules market outlook in North America is the increasing prevalence of chronic disorders. As per National Library of Medicine, the number of people in the United States aged 50 years and older will increase by 61.11% from 137.25 million in 2020 to 221.13 million in 2050.Of the population 50 years and older, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Owing mostly to aging populations and lifestyle choices, conditions like diabetes, cardiovascular illnesses, and gastrointestinal ailments are prevalent in the area. Enteric softgel capsules provide targeted and sustained release of medications, which is beneficial for patients with chronic conditions who often need long-term treatment. These capsules are a recommended option for managing chronic diseases since they enhance therapeutic outcomes and minimize adverse effects. The substantial market share of North America is mostly attributed to the rising prevalence of chronic illnesses, which in turn drives demand for efficient and practical drug delivery methods.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major enteric softgel capsules companies in the industry include Aenova Group GmbH, BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsule Co., Ltd., Lonza Group AG, Now Health Group, Inc., ProCaps Group, Super Spectrim and Thermo Fisher Scientific, Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • As per enteric softgel capsules market research report, key players are establishing strategic alliances and partnerships to strengthen their position. They are also innovating through collaboration with academic institutions, research centers, and other pharmaceutical firms. These partnerships frequently result in the exchange of technology and information as well as the co-development of new goods, all of which greatly strengthen a business's competitive advantage. Increasing production capacity is yet another important tactic used by top competitors in the enteric softgel capsule industry. Businesses can boost production capacity and boost operational efficiency by investing in new production facilities or renovating existing ones. Moreover, companies are entering emerging markets, where the demand for advanced pharmaceutical products is rising, which is providing significant growth opportunities.

Key Questions Answered in This Report

  • 1.What was the size of the global enteric softgel capsules market in 2024?
  • 2.What is the expected growth rate of the global enteric softgel capsules market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global enteric softgel capsules market?
  • 4.What are the key factors driving the global enteric softgel capsules market?
  • 5.What is the breakup of the global enteric softgel capsules market based on the type?
  • 6.What is the breakup of the global enteric softgel capsules market based on the application?
  • 7.What is the breakup of the global enteric softgel capsules market based on the distribution channel?
  • 8.What are the key regions in the global enteric softgel capsules market?
  • 9.Who are the key players/companies in the global enteric softgel capsules market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Enteric Softgel Capsules Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Gelatin Capsules
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-Gelatin Softgel Capsules
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Health Supplements
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pharmaceuticals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Supermarkets and Hypermarkets
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmacy and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Aenova Group GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 BASF SE
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Catalent, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Colorcon Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Fuji Capsule Co., Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Lonza Group AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Now Health Group, Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 ProCaps Group
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Super Spectrim
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific, Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Enteric Softgel Capsules Market: Major Drivers and Challenges
  • Figure 2: Global: Enteric Softgel Capsules Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Enteric Softgel Capsules Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Enteric Softgel Capsules Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Enteric Softgel Capsules Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Enteric Softgel Capsules Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Enteric Softgel Capsules Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Enteric Softgel Capsules (Gelatin Capsules) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Enteric Softgel Capsules (Gelatin Capsules) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Enteric Softgel Capsules (Non-Gelatin Softgel Capsules) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Enteric Softgel Capsules (Non-Gelatin Softgel Capsules) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Enteric Softgel Capsules (Health Supplements) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Enteric Softgel Capsules (Health Supplements) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Enteric Softgel Capsules (Pharmaceuticals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Enteric Softgel Capsules (Pharmaceuticals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Enteric Softgel Capsules (Supermarkets and Hypermarkets) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Enteric Softgel Capsules (Supermarkets and Hypermarkets) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Enteric Softgel Capsules (Pharmacy and Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Enteric Softgel Capsules (Pharmacy and Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Enteric Softgel Capsules (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Enteric Softgel Capsules (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: North America: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: North America: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: United States: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: United States: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Canada: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Canada: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Asia-Pacific: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Asia-Pacific: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: China: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: China: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Japan: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Japan: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: India: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: India: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: South Korea: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: South Korea: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Australia: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Australia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Indonesia: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Indonesia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Others: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Europe: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Europe: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Germany: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Germany: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: France: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: France: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: United Kingdom: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: United Kingdom: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Italy: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Italy: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Spain: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Spain: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Russia: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Russia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Latin America: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Latin America: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Brazil: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Brazil: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Mexico: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Mexico: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Middle East and Africa: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Middle East and Africa: Enteric Softgel Capsules Market: Breakup by Country (in %), 2024
  • Figure 70: Middle East and Africa: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Global: Enteric Softgel Capsules Industry: SWOT Analysis
  • Figure 72: Global: Enteric Softgel Capsules Industry: Value Chain Analysis
  • Figure 73: Global: Enteric Softgel Capsules Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Enteric Softgel Capsules Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Enteric Softgel Capsules Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Enteric Softgel Capsules Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Enteric Softgel Capsules Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Enteric Softgel Capsules Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Enteric Softgel Capsules Market: Competitive Structure
  • Table 7: Global: Enteric Softgel Capsules Market: Key Players